Elanco Animal Valuation

5EA Stock  EUR 11.95  0.19  1.62%   
At this time, the firm appears to be fairly valued. Elanco Animal Health shows a prevailing Real Value of €11.92 per share. The current price of the firm is €11.95. Our model computes the value of Elanco Animal Health from reviewing the firm fundamentals such as Operating Margin of 0.09 %, current valuation of 10.92 B, and Profit Margin of (0.02) % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
11.95
Please note that Elanco Animal's price fluctuation is not too volatile at this time. Calculation of the real value of Elanco Animal Health is based on 3 months time horizon. Increasing Elanco Animal's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elanco stock is determined by what a typical buyer is willing to pay for full or partial control of Elanco Animal Health. Since Elanco Animal is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elanco Stock. However, Elanco Animal's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  11.95 Real  11.92 Hype  11.95
The real value of Elanco Stock, also known as its intrinsic value, is the underlying worth of Elanco Animal Health Company, which is reflected in its stock price. It is based on Elanco Animal's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Elanco Animal's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
11.92
Real Value
14.69
Upside
Estimating the potential upside or downside of Elanco Animal Health helps investors to forecast how Elanco stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elanco Animal more accurately as focusing exclusively on Elanco Animal's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
9.1811.9514.72
Details

Elanco Animal Total Value Analysis

Elanco Animal Health is presently estimated to have takeover price of 10.92 B with market capitalization of 5.6 B, debt of 6.03 B, and cash on hands of 515 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Elanco Animal fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
10.92 B
5.6 B
6.03 B
515 M

Elanco Animal Investor Information

About 100.0% of the company shares are owned by institutions such as pension funds. The company has Price-to-Book (P/B) ratio of 0.89. In the past many companies with similar price-to-book ratios have beat the market. Elanco Animal Health has Price/Earnings To Growth (PEG) ratio of 1.86. The entity recorded a loss per share of 0.14. The firm had not issued any dividends in recent years. Elanco Animal Health is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Elanco Animal Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elanco Animal has an asset utilization ratio of 26.8 percent. This implies that the Company is making €0.27 for each dollar of assets. An increasing asset utilization means that Elanco Animal Health is more efficient with each dollar of assets it utilizes for everyday operations.

Elanco Animal Ownership Allocation

Elanco Animal Health retains a total of 474.2 Million outstanding shares. The majority of Elanco Animal Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Elanco Animal Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Elanco Animal. Please pay attention to any change in the institutional holdings of Elanco Animal Health as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Elanco Animal Profitability Analysis

The company reported the revenue of 4.42 B. Net Loss for the year was (74 M) with profit before overhead, payroll, taxes, and interest of 2.5 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Elanco Animal's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Elanco Animal and how it compares across the competition.

About Elanco Animal Valuation

The stock valuation mechanism determines Elanco Animal's current worth on a weekly basis. Our valuation model uses a comparative analysis of Elanco Animal. We calculate exposure to Elanco Animal's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elanco Animal's related companies.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. ELANCO ANIMAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10200 people.

8 Steps to conduct Elanco Animal's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Elanco Animal's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Elanco Animal's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Elanco Animal's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Elanco Animal's revenue streams: Identify Elanco Animal's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Elanco Animal's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Elanco Animal's growth potential: Evaluate Elanco Animal's management, business model, and growth potential.
  • Determine Elanco Animal's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Elanco Animal's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Elanco Stock analysis

When running Elanco Animal's price analysis, check to measure Elanco Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elanco Animal is operating at the current time. Most of Elanco Animal's value examination focuses on studying past and present price action to predict the probability of Elanco Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elanco Animal's price. Additionally, you may evaluate how the addition of Elanco Animal to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals